Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health Inc
(NY:
HIMS
)
32.22
UNCHANGED
Streaming Delayed Price
Updated: 5:00 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health Inc
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
December 01, 2024
8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 29, 2024
Via
Benzinga
Exploring growth characteristics of HIMS & HERS HEALTH INC (NYSE:HIMS).
November 28, 2024
Should you consider HIMS & HERS HEALTH INC (NYSE:HIMS) for growth investing?
Via
Chartmill
Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
November 28, 2024
Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines.
Via
MarketBeat
Topics
Government
Exposures
COVID-19
Political
Product Safety
Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity
November 27, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Hims & Hers Health
November 18, 2024
Via
Benzinga
Price Over Earnings Overview: Hims & Hers Health
November 18, 2024
Via
Benzinga
Why Hims & Hers Stock Jumped on Massive FDA News
November 26, 2024
Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.
Via
The Motley Fool
Exposures
Product Safety
Technical Monday: A Fresh Look At The “Vanity” Trade
November 25, 2024
Nu Skin is an American multi-level marketing company for personal care products and dietary supplements.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
What's Going On With Hims & Hers Health Stock Monday?
November 25, 2024
Shares of Hims & Hers Health, Inc. (NYSE: HIMS) traded higher on Monday in response to President-elect Donald Trump's plans to nominate Marty Makary to lead the Food and Drug Administration (FDA)....
Via
Benzinga
Topics
Government
Exposures
Political
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
November 25, 2024
Via
Benzinga
Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?
November 24, 2024
The top performers in the last week were Lemonade, Inc., Archer Aviation Inc., C3.ai, Inc., Oklo Inc., Applied Digital Corporation, Unity Software Inc., Nebius Group N.V., NuScale Power Corporation,...
Via
Benzinga
Should You Buy Hims & Hers Stock on the Dip?
November 16, 2024
Via
The Motley Fool
Peering Into Hims & Hers Health's Recent Short Interest
November 15, 2024
Via
Benzinga
Hims & Hers New Growth Category Is a Huge Surprise
November 22, 2024
Is the food business the right business for Hims & Hers to be in?
Via
The Motley Fool
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
November 21, 2024
From
Hims & Hers
Via
Business Wire
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock?
November 20, 2024
Via
The Motley Fool
Guardant Health Stock Sees RS Rating Jump To 83
November 20, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.
Via
Investor's Business Daily
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
November 18, 2024
From
Hims & Hers
Via
Business Wire
Unpacking the Latest Options Trading Trends in Hims & Hers Health
November 12, 2024
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Nov. 16
November 16, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Nov. 11-15, 2024.
Via
Talk Markets
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
November 16, 2024
Hims & Hers has given back recent gains, but don't overlook the company's massive growth.
Via
The Motley Fool
From Volatility To Opportunity: Key Stocks Poised To Shine Today
November 15, 2024
Volatile market? Learn how RCAT, ROOT, and GEO stand out with robust catalysts, sentiment, and fundamentals.
Via
Talk Markets
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
November 14, 2024
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new upfront pricing for telehealth visits and treatment plans.
Via
Benzinga
What's Going On With Hims & Hers Health Stock On Wednesday?
November 13, 2024
Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing rising demand and pharmacy shortages.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
Via
Benzinga
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
November 13, 2024
From
Hims & Hers
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
November 12, 2024
Via
Benzinga
Up 298% in a Year, Is Hims & Hers Health Still a Buy?
November 12, 2024
The healthcare company is on fire, and it's still cheap by many measures.
Via
The Motley Fool
3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
November 12, 2024
Hims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to watch for growth potential
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.